Synthesis and Characterization of Rim4 and Corresponding Zn

II
Complexes
General: solvents and reagents were obtained commercially. DMF (anhydrous 99.8 %) was stored over 4 Å molecular sieves and under Argon. THF was freshly distilled over sodium/benzophenone under Argon. Resorcinarene tetra(alcohol) 1 and 2-chloromethyl-1-methyl-1H-imidazole were synthesized according to literature procedures. 1, 2 NMR spectra were recorded with a Varian VNMRS 600 MHz spectrometer, Bruker ARX 250 MHz spectrometer or an Advance 500 spectrometer (500 MHz). Standard HSQC and HMBC experiments were used for peak assignments. MS (ESI) analyses were obtained with a ThermoFinnigen LCQ Advantage spectrometer using methanol, dichloromethane or acetonitrile as solvents. IR spectra were obtained with a Perkin-Elmer Spectrum on FTIR spectrometer equipped with a MIRacleTM single reflection horizontal ATR unit (germanium crystal).
Safety note. Caution! Although we have not encountered any problems, it is noted that perchlorate salts of metal complexes with organic ligands are potentially explosive and should be handled only in small quantities and with appropriate precautions.
Tetra(imidazole) cavitand Rim4
Tetra(alcohol)cavitand 1 (0.45 mmol; 420 mg) was dissolved in freshly distilled THF (4 mL). The solution was evaporated under vacuum at 80 °C for 1 h in order to eliminate traces of water. This operation was repeated 3 times. Under argon at 0 °C, compound 1 was then dissolved in dry DMF (8 mL) and added dropwise to a suspension of NaH (14 mmol; 544 mg of a 60% dispersion washed with n-pentane) in dry DMF (5 mL). The reaction mixture was then stirred for 30 min at 0 °C and two additional hours at room temperature. At 0 °C, 2-chloromethyl-1-methyl-1H-imidazole (3.6 mmol; 606 mg) was added in 4 portions into the mixture every 15 min. The resulting orange suspension was stirred overnight at room temperature. The mixture was hydrolyzed at 0 °C with water (60 mL). The resulting solid was filtered off, washed with water (2 x 20 mL), then ammonia 2% (20 mL) and water (20 mL). The resulting powder was redissolved in dichloromethane (10 mL), dried over Na2SO4, filtered and evaporated to yield an off-white solid (511 mg). This solid was purified over silica (DCM/MeOH 9:1 to 8:2 with 0.3 % NH3). The solid obtained was dissolved in 3 mL chloroform and washed with NaOH 1 M (2 mL) and twice with water (2 mL). The organic layer was dried over Na2SO4 and evaporated. The obtained solid was recristallized from EtOH/H2O 1:1 (4 mL) to yield an off-white powder (389 mg, 64%). IR:  = 2925. 8, 2856.2, 1654.5, 1590.1, 1499.1, 1458.5, 1400.1, 1347.6, 1284.3, 1241.5, 1149.4, 1066.7, 968.5, 746.9 
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Zinc complex [Rim4Zn(EtOH)](ClO4)2
Ligand Rim4 (0.035 mmol; 46 mg) was dissolved in degassed EtOH (1 mL) under argon and added dropwise to a solution of Zn(ClO4)2.6H2O (0.035 mmol; 13 mg) in degassed EtOH (1 mL). A white solid precipitated during the addition and the resulting mixture was stirred for an additional hour under argon. After centrifugation, the white solid was separated, washed twice with EtOH (1mL) and then dried under vacuum at 60 °C for 2 h, yielding a white solid (48 mg, 85%). The NMR of the solid revealed the presence of 1 eq EtOH that is likely bound to the Zn II center when the complex precipitates and replaced by acetonitrile when dissolved in this solvent. IR:  = 2929. 2, 2861.0, 1634.5, 1591.8, 1506.0, 1457.0, 1287.8, 1242.5, 1151.5, 1087.3, 1019.6, 970.3, 755.0, 667.7, 623.6 
Acetato Zinc complex [Rim4Zn(OAc)](ClO4)
[Rim4Zn(EtOH)](ClO4)2 (0.0057 mmol; 9 mg) was dissolved in acetonitrile (2 mL) and NaOAc (excess, ca. 1 mg as a solid) was added to the solution. The resulting suspension was sonicated then stirred for 20 minutes. The suspension was filtered via a syringe filter, evaporated, washed with water (2 mL), then dried under vacuum yielding a tanned powder (8.7 mg, 99%). =2935.8, 2865.3, 1590.3, 1458.7, 1290.1, 1241.2, 1150.6, 1087.8, 1018.6, 965.9, 882.3, 756.8, 680.8, 623 .6 (ClO4 Figure 6 and Figures S29-S35) by the peak at -2.40 ppm accounting for the presence of one equivalent relative to the resorcinarene core of acetamide bound in the cavity. The latter is readily displaced by acetate through addition of AcOH. Figure S13 . NMR DOSY spectrum of Rim4 (600 MHz, CD3CN, 300 K). (ClO4)2, +0.5 eq benzoylacetone, + 1.5 eq, +1.5 eq benzoylacetone/+1 eq NEt3, +3 eq benzoylacetone/2.5 eq NEt3, +5 eq benzoylacetone/4.5 eq NEt3 (500 MHz, CD3CN, 300 K). Inset: zoomed intracavity region. Figure S28 . Titration of [Rim4Zn(S)](ClO4)2 (2 mM) with formic acid then NEt3. Bottom to top: [Rim4Zn(S)](ClO4)2, +0.5 eq formic acid, +1.5 eq formic acid, +1.5 eq formic acid/+1 eq NEt3 (250 MHz, CD3CN, 300 K). Red dots indicate the signal for included formate. (ClO4)2, +0.5 eq propionic acid, +1.5 eq propionic acid, +2.7 eq propionic acid, +2.7 eq propionic acid/+1 eq NEt3 (250 MHz, CD3CN, 300 K). Red dots indicate included propionate. Kinetic measurements. [Rim4Zn(EtOH)](ClO4)2 (2.1 mg, 3 mM) was dissolved in 0.5 mL of CH3CN/CD3CN (8:2) and water (5 to 35%) in an NMR tube with DMF (5.2 mM) as a reference for integrations. The tube was rapidly introduced in a 500 MHz NMR spectrometer set at 343 K and spectra (6 scans) were recorded every 30 s. The growing intracavity signal at -2.40 ppm was integrated to follow and quantify acetamide formation. The tube was then heated for 8 days at 343 K and NMR spectra (32 scans) were recorded twice a day. The integration of the amide NH protons allowed to quantify acetamide formation over time. A previously reported equation for catalysis inhibited by product displacement Biol. Chem., 1970, 245, 5788-5799. 
DOSY Experiments
